Heparan sulfate in immune responses

Annals of the New York Academy of Sciences

Volumn 797, Issue , 1996, Pages 127-139

  Selvan, Rathinam S ^a   Ihrcke, Nathan S ^a   Platt, Jeffrey L ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHEMOKINE; CYTOKINE; GROWTH FACTOR; PROTEINASE INHIBITOR; PROTEOHEPARAN SULFATE;

B LYMPHOCYTE; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CONFERENCE PAPER; DRUG METABOLISM; ENDOTHELIUM CELL; ENZYME RELEASE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MACROPHAGE; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STEM CELL; T LYMPHOCYTE;

EID: 0030451546     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52955.x     Document Type: Conference Paper

References (109)

1. LINDAHL, U. & L. KJELLEN. 1991. Heparin or heparan sulfate: What is the difference? Thromb. Haemostasis 66: 44-48.
2. KATO, M., H. WANG, M. BERNFIELD, J. T. GALLAGHER & J. E. TURNBULL. 1994. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J. Biol. Chem. 269: 18881-18890.
3. PARTHASARATHY, N., I. J. GOLDBERG, P. SIVARAM, B. MULLOY, D. M. FLORY & W. D. WAGNER. 1994. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J. Biol. Chem. 269: 22391-22396.
4. MARCUM, J. A. & R. D. ROSENBERG. 1987. Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin. Thromb. Hemostasis. 13: 464-474.
5. MACH, H., D. B. VOLKIN, C. J. BURKE, C. R. MIDDAUGH, R. J. LINDHARDT, J. R. FROMM & D. LOGANATHAN. 1993. Nature of interaction of heparin with acidic fibroblast growth factor. Biochemistry 32: 5480-5489.
6. TURNBULL, J. E., D. G. FERNIG, Y. KE, M. C. WILKINSON & J. T. GALLAGHER. 1992. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267: 10337-10341.
7. LYON, M., J. A. DEAKIN, K. MIZUNO, T. NAKAMURA & J. T. GALLAGHER. 1994. Interaction of hepatocyte growth factor with heparan sulfate. J. Biol. Chem. 269: 11216-11223.
8. LINDBLOM, A., G. BENGTSSON-OLIVECRONA & L. FRANSSON. 1991. Domain structure of endothelial cell heparan sulfate. Biochem. J. 279: 821-829.
9. SALMIVIRTA, M., K. ELENIUS, S. VAINIO, U. HOFER, R. CHIQUET-EHRISMANN, I. THESLEFF & M. JALKANEN. 1991. Syndecan from embryonic tooth mesenchyme binds tenascin. J. Biol. Chem. 266: 7733-7739.
10. BERNFIELD, M., M. T. HINKES & R. L. GALLO. 1993. Developmental expression of the syndecans: Possible function and regulation. Development (Suppl.): 205-212.
11. BAI, X. M., B. VAN DER SCHUEREN, J. CASSIMAN, H. VAN DEN BERGHE & G. DAVID. 1994. Differential expression of multiple cell-surface heparan sulfate proteoglycans during embryonic tooth development. J. Histochem. Cytochem. 42: 1043-1056.
12. BERNFIELD, M., R. KOKENYESI, M. KATO, M. T. HINKES, J. SPRING, R. L. GALLO & E. J. LOSE. 1992. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8: 365-393.
13. DAVID, G., V. LORIES, B. DECOCK, P. MARYNEN, J. CASSIMAN & H. VAN DEN BERGHE. 1990. Molecular cloning of phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblast. J. Cell Biol. 111: 3165-3176.
14. STIPP, C. S., E. D. LITWACK & A. D. LANDER. 1994. Cerebroglycan: An integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J. Cell Biol. 124: 149-160.
15. MURDOCH, A. D., G. R. DODGE, I. COHEN, R. S. TUAN & R. V. IOZZO. 1992. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG-2/perlecan). J. Biol. Chem. 267: 8544-8557.
16. ROBERTS, R., J. GALLAGHER, E. SPOONCER, T. D. ALLEN, F. BLOOMFIELD & T. M. DEXTER. 1988. Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haematopoiesis. Nature 332: 376-378.
17. GORDON, M. Y., G. P. RILEY & D. CLARKE. 1988. Heparan sulfate is necessary for adhesive interactions between human early hematopoietic progenitor cells and the extracellular matrix of the microenvironment. Leukemia 2: 804-809.
18. KOLSET, S. O. & J. T. GALLAGHER. 1990. Proteoglycans in haemopoietic cells. Biochem. Biophys. Acta 1032: 191-211.
19. MIYAKE, K., K. L. MEDINA, S. HAYASHI, S. ONO, T. HAMAOKA & P. W. KINCADE. 1990. Monoclonal antibodies to pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171: 477-488.
20. MIYAKE, K., C. B. UNDERHILL, J. LESLEY & P. W. KINCADE. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172: 69-75.
21. RYAN, D. H., B. L. NUCCIE, C. N. ABBOUD & J. M. WINSLOW. 1991. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 88: 995-1004.
22. BALLARD, L. L., E. J. BROWN & V. M. HOLERS. 1991. Expression of the fibronectin receptor VLA-5 is regulated during human B cell differentiation and activation, Clin. Exp. Immunol. 84: 336-346.
23. MIYAKE, K., I. L. WEISSMAN, J. S. GREENBERGER & P. W. KINCADE. 1991. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. 173: 599-607.
24. MIYAKE, K., K. MEDINA, K. ISHIHARA, M. KIMOTO, R. AUERBACH & P. W. KINCADE. 1991. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. 114: 557-565.
25. SICZKOWSKI, M., D. CLARKE & M. Y. GORDON. 1992. Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. Blood 80: 912-919.
26. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 82: 2649-2663.
27. ROBERTS, R. A., E. SPOONCER, E. K. PARKINSON, B. I. LORD, T. D. ALLEN & T. M. DEXTER. 1987. Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J. Cell. Physiol. 132: 203-214.
28. COOMBE, D. R., S. M. WATT & C. R. PARISH. 1994. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 3: 739-752.
29. KINCADE, P. W., G. LEE, C. E. PIETRANGELI, S. HAYASHI & J. M. GIMBLE. 1989. Cells and molecules that regulate B-lymphopoiesis in bone marrow. Ann. Rev. Immunol. 7: 111-143.
30. SANDERSON, R. D., P. LALOR & M. BERNFIELD. 1989. B-lymphocytes express and lose syndecan at specific stages of differentiation. Cell Reg. 1: 27-35.
31. SANDERSON, R. D., T. B. SNEED, L. A. YOUNG, G. L. SULLIVAN & A. D. LANDER. 1992. Adhesions of B-lymphoid (MPC-11) cells to type 1 collagen is mediated by the integral membrane proteoglycan, syndecan. J. Immunol. 148: 3902-3911.
32. + cells. EMBO J. 8: 4053-4063.
33. GUTIERREZ, J. C. & R. PALACIOS. 1991. Heterogeneity of thymic epithelial cells in promoting T-lymphocyte differentiation in vivo. Proc. Natl. Acad. Sci. USA 88: 642-646.
34. WRENSHALL, L. E., F. B. CERRA, P. RUBINSTEIN & J. L. PLATT. 1993. Regulation by heparan sulfate and interleukin-1α of the ontogenic expression of T-cell receptor, CD4, and CD8 in developing thymus. Hum. Immunol. 38: 165-171.
35. WRENSHALL, L. E., F. B. CERRA, A. CARLSON, F. H. BACH & J. L. PLATT. 1991. Regulation of murine splenocyte responses by heparan sulfate. J. Immunol. 147: 455-459.
36. WRENSHALL, L. E., A. CARLSON, F. B. CERRA & J. L. PLATT. 1994. Modulation of cytolytic T-cell responses by heparan sulfate. Transplantation 57: 1087-1094.
37. WRENSHALL, L. E., F. B. CERRA, R. K. SINGH & J. L. PLATT. 1995. Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes. J. Immunol. 154: 871-880.
38. ZELLWEGER, R., A. AYALA, X. ZHU, K. R. HOLME, C. M. DEMASO & I. H. CHAUDRY. 1995. A novel nonanticoagulant heparin improves splenocyte and peritoneal macrophage immune function after trauma-hemorrhage and resuscitation. J. Surg. Res. 59: 211-218.
39. BUTCHER, E. C. 1991. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
40. SHIMIZU, Y., W. NEWMAN, Y. TANAKA & S. SHAW. 1992. Lymphocyte interactions with endothelial cells. Immunol. Today 13: 106-112.
41. PARDI, R., L. INVERARDI & J. R. BENDER. 1992. Regulatory mechanisms in leukocyte adhesion: Flexible receptors for sophisticated travelers. Immunol. Today 13: 224-230.
42. TANAKA, Y., D. ADAMS & S. SHAW. 1993. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today 14: 111-115.
43. SPRINGER, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314.
44. SCHALL, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3: 165-183.
45. MILLER, M. D. & M. S. KRANGEL. 1992. Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12: 17-46.
46. BAGGIOLINI, M., B. DEWALD & B. MOSER. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55: 97-179.
47. KELNER, G. S., J. KENNEDY, K. B. BACON, S. KLEYENSTEUBER, D. A. LARGAESPADA, N. A. JENKINS, N. G. COPELAND, J. F. BAZAN, K. W. MOORE, T. J. SCHALL & A. ZLOTNIK. 1994. Lymphotactin: A cytokine that represents a new class of chemokine. Science 266: 1395-1399.
48. HUBER, A. R., S. L. KUNKEL, R. F. TODD & S. J. WEISS. 1991. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254: 99-102.
49. NATHAN, C. & M. SPORN. 1991. Cytokines in context. J. Cell Biol. 113: 981-986.
50. LORTAT-JACOB, H. & J. A. GRIMAUD. 1991. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity. Cell. Mol. Biol. 37: 253-260.
51. ROT, A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13: 291-294.
52. TANAKA, Y., D. H. ADAMS, S. HUBSCHER, H. HIRANO, U. SIEBENLIST & S. SHAW. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature 361: 79-82.
53. + T lymphocytes to interact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1β. J. Immunol. 153: 4899-1906.
54. WEBB, L. M. C., M. U. EHRENGRUBER, I. CLARK-LEWIS, M. BAGGIOLINI & A. ROT. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin-8. Proc. Natl. Acad. Sci. USA 90: 7158-7162.
55. YAYON, A., M. KLAGSBRUN, J. D. ESKO, P. LEDER & D. M. ORNITZ. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
56. AVIEZER, D., D. HECHT, M. SAFRAN, M. EISINGER, G. DAVID & A. YAYON. 1994. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79: 1005-1013.
57. WITT, D. P. & A. D. LANDER. 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4: 394-400.
58. SCHONBECK, U., E. BRANDT, F. PETERSEN, H. D. FLAD & H. LOPPNOW. 1995. IL-8 specifically binds to endothelial but not to smooth muscle cells. J. Immunol. 154: 2375-2383.
59. HANDIN, R. I. & H. J. COHEN. 1976. Purification and binding properties of human platelet factor-4. J. Biol. Chem. 251: 4273-4282.
60. MAIONE, T. E., G. S. GRAY, J. PETRO, A. J. HUNT, A. L. DONNER, S. I. BAUER, H. F. CARSON & R. J. SHARPE. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77-79.
61. HAN, Z. C., L. SENSEBE, J. F. ABRGALL & J. BRIERE. 1990. Platelet factor-4 inhibits human megakaryocytopoiesis in vitro. Blood 75: 1234-1239.
62. WATSON, J. B., S. B. GETZIER & D. F. MOSHER. 1994. Platelet factor-4 modulates the mitogenic activity of basic fibroblast growth factor. J. Clin. Invest. 94: 261-268.
63. LUSTER, A. D., S. M. GREENBERG & P. LEDER. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor-4 and inhibits endothelial cell proliferation. J. Exp. Med. 182: 219-231.
64. NAKAZONO, K., N. WATANABE, K. MATSUNO, J. SASAKI, T. SATO & M. INOUE. 1991. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA 88: 10045-10048.
65. ABRAHAMSSON, T., U. BRANDT, S. L. MARKLUND & P. SJOQUIST. 1992. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ. Res. 70: 264-271.
66. KARLSSON, K. & S. L. MARKLUND. 1988. Plasma clearance of human extracellular-superoxide dismutase C in rabbits. J. Clin. Invest. 82: 726-766.
67. REDINI, F., J. TIXIER, M. PETITOU, J. CHOAY, L. ROBERT & W. HORNEBECK. 1988. Inhibition of leucocyte elastase by heparin and its derivatives. Biochem. J. 252: 515-519.
68. PETZELBAUER, E., D. SEIFFERT, R. BECKMANN, B. PUSCH, M. GEIGER & B. R. BINDER. 1992. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. Thromb. Res. 66: 559-567.
69. EHRLICH, H. J., J. KEIJER, K. T. PREISSNER, R. K. GEBBINK & H. PANNEKOEK. 1991. Functional interactions of plasminogen activator inhibitor type 1 (PAI-1) and heparin. Biochemistry 30: 1021-1028.
70. FARRELL, D. H. & D. D. CUNNINGHAM. 1986. Human fibroblasts accelerate the inhibition of thrombin by protease nexin-1. Proc. Natl. Acad. Sci. USA 83: 6858-6862.
71. FARRELL, D. H. & D. D. CUNNINGHAM. 1987. Glycosaminoglycans on fibroblasts accelerate thrombin inhibition by protease nexin-1. Biochem. J. 245: 543-550.
72. IHRCKE, N. S., L. E. WRENSHALL, B. J. LINDMAN & J. L. PLATT. 1993. Role of heparan sulfate in immune system-blood vessel interactions. Immunol. Today 14: 500-505.
73. (a) VLODAVSKY, I., A. ELDOR, A. HAIMOVITZ-FRIEDMAN, R. ISHAI-MICHAELI, O. LIDER, Y. NAPARSTEK, I. R. COHEN & Z. FUKS. 1992. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Invasion & Metastasis 12: 112-127.
74. (b) PLATT, J. L., A. P. DALMASSO, B. J. LINDMAN, N. S. IHRCKE & F. H. BACH. 1991. The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur. J. Immunol. 21: 2887-2890.
75. (a) METZ, C. N., G. BRUNNER, N. H. CHOI-MUIRA, H. NGUYEN, J. GABRILOVE, I. W. CARAS, N. ALTSZULER, D. B. RIFKIN, E. L. WILSON & M. A. DAVITZ. 1994. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J. 13: 1741-1751.
76. (b) PLATT, J. L., G. M. VERCELLOTTI, B. J. LINDMAN, T. R. OEGEMA, JR., F. H. BACH & A. P. DALMASSO. 1990. Release of heparan sulfate from endothelial cells: Implications for pathogenesis of hyperacute rejection. J. Exp. Med. 171: 1363-1368.
77. (c) IHRCKE, N. S. & J. L. PLATT. 1996. Shedding of heparan sulfate proteolgycan by stimulated endothelial cells: Evidence for proteolysis of cell surface molecules. J. Cell. Physiol. In press.
78. KEY, N. S., J. L. PLATT & G. M. VERCELLOTTI. 1992. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterioscler. Thromb. 12: 836-842.
79. SAKSELA, O. & D. RIFKIN. 1990. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110: 767-775.
80. RIFKIN, D. 1992. Plasminogen activator expression and matrix degradation. Matrix 1: 20-22.
81. GELLER, R. L., N. S. IHRCKE & J. L. PLATT. 1994. Release of endothelial cell-associated heparan sulfate proteoglycan by activated T cells. Transplantation 57: 770-774.
82. HAIMOVITZ-FRIEDMAN, A., D. J. FALCONE, A. ELDOR, V. SCHMIRRMACHER, I. VLODAVSKY & Z. FUKS. 1991. Activation of platelet heparitinase by tumor cell-derived factors. Blood 78: 789-796.
83. WASTESON, A., B. GLIMELIUS, C. BUSCH, B. WESTERMARK, C. HELDIN & B. NORLING. 1977. Effect of platelet endoglycosidase on cell surface associated heparan sulphate of human cultured endothelial and glial cells. Thromb. Res. 11: 309-321.
84. NAPARSTEK, Y., I. R. COHEN, Z. FUKS & I. VLODAVSKY. 1984. Activated T-lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature 310: 241-244.
85. LASKOV, R., R. I. MICHAELI, H. SHARIR, E. YEFENOF & I. VLODAVSKY. 1991. Production of heparanse by normal and neoplastic murine B-lymphocytes. Int. J. Cancer 47: 92-98.
86. HOOGEWERF, A. J., J. W. LEONE, I. M. REARDON, W. J. HOWE, D. ASA, R. L. HEINRIKSON & S. R. LEDBETTER. 1995. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem. 270: 3268-3277.
87. GILAT, D., R. HERSHKOVIZ, I. GOLDKORN, L. CAHALON, G. KORNER, I. VLODAVSKY & O. LIDER. 1995. Molecular behavior adapts to context: Heparanase functions as an extracellular matrix-degrading enzyme or as a T-cell adhesion molecule, depending on the local pH. J. Exp. Med. 181: 1929-1934.
88. COLBURN, P., E. KOBAYASHI & V. BUONASSISI. 1994. Depleted level of heparan sulfate proteoglycan in the extracellular matrix of endothelial cell cultures exposed to endotoxin. J. Cell. Physiol. 159: 121-130.
89. RAMASAMY, S., D. W. LIPKE, C. J. MCCLAIN & B. HENNIG. 1995. Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J. Cell. Physiol. 162: 119-126.
90. KOBAYASHI, M., K. SHIMADA & T. OZAWA. 1992. Human platelet-derived transforming growth factor-β stimulates synthesis of glycosaminoglycans in cultured porcine aortic endothelial cells. Gerontology 38(Suppl. 1): 36-42.
91. AKAI, T., T. KAJI, Y. HAYAKAWA, T. HAYASHI & N. SAKURAGAWA. 1991. Antithrombin III modulates the effect of thrombin on the metabolism of glycosaminoglycans in cultured endothelial cells. Thromb. Res. 62: 707-716.
92. KAJI, T., S. HIRAGA, C. YAMAMOTO, M. SAKAMOTO, Y. NAKASHIMA, K. SUEISHI & F. KOIZUMI. 1993. Tumor necrosis factor alpha-induced alteration of glycosaminoglycans in cultured vascular smooth-muscle cells. Biochim. Biophys. Acta 1176: 20-26.
93. SHIMADA, K., M. KOBAYASHI & T. OZAWA. 1989. The modulation of heparin-like activity of endothelial cells in experimental systems. Acta Haematol. Jpn. 52: 1337-1342.
94. NADER, H. B., L. TOMA, M. A. S. PINHAL, V. BUONASSISI, P. COLBURN & C. P. DIETRICH. 1991. Effect of heparin and dextran sulfate on the synthesis and structure of heparan sulfate from cultured endothelial cells. Semin. Thromb. Hemostasis 17(Suppl. 1): 47-56.
95. NADER, H. B., V. BUONASSISI, P. COLBURN & C. P. DIETRICH. 1989. Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J. Cell. Physiol. 140: 305-310.
96. BOUDREAU, N., N. CLAUSELL, J. BOYLE & M. RABINOVITCH. 1992. Transforming growth factor-β regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation. Lab. Invest. 67: 350-359.
97. HUMPHERIES, D. E., S. LEE, B. L. FANBURG & J. E. SILBERT. 1986. Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells. J. Cell. Physiol. 126: 249-253.
98. LARK, M. W. & L. A. CULP. 1984. Turnover of heparan sulfate proteoglycans from substratum adhesion sites of murine fibroblasts. J. Biol. Chem. 259: 212-217.
99. KINSELLA, M. G. & T. N. WIGHT. 1986. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J. Cell Biol. 102: 679-687.
100. LARK, M. W. & L. A. CULP. 1984. Multiple classes of heparan sulfate proteoglycans from fibroblast substratum adhesion sites. J. Biol. Chem. 259: 6773-6782.
101. NAKAJIMA, M., A. DECHAVIGNY, C. E. JOHNSON, J. HAMADA, C. A. STEIN & G. L. NICOLSON. 1991. Suramin: A potent inhibitor of melanoma heparanase and invasion. J. Biol. Chem. 266: 9661-9666.
102. BAR-NER, M., M. D. KRAMER, V. SCHIRRMACHERR, R. ISHAI-MICHAELI, Z. FUKS & I. VLODAVSKY. 1985. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int. J. Cancer 35: 483-491.
103. MATZNER, Y., M. BAR-NER, J. YAHALOM, R. ISHAI-MICHAELI, Z. FUKS & I. VLODAVSKY. 1985. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils: Possible role in invasion through basement membranes. J. Clin. Invest. 76: 1306-1313.
104. KANWAR, Y. S., A. LINKER & M. G. FAROUHAR. 1980. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J. Cell Biol. 86: 688-693.
105. WEILER, J. M. & R. J. LINHARDT. 1991. Antithrombin III regulates complement activity in vitro. J. Immunol. 146: 3889-3894.
106. THUNDBERG, L., G. BACKSTROM, A. WASTESON, H. C. ROBINSON, S. OGREN & U. LINDAHL. 1982. Enzymatic depolymerization of heparin-related polysaccharides. J. Biol. Chem. 257: 10278-10282.
107. PLATT, J. L. 1995. Xenotransplantation: The need, the immunologic hurdles and the prospects for success. ILAR J. 37: 22-31.
108. RADI, R., P. C. PANUS, J. A. ROYALL, A. PALER-MARTINEZ & B. A. FREEMAN. 1992. Generation of Reactive Species by Vascular Endothelium. Biological Oxidants: Generation and Injurious Consequences. C. G. Cochrane & M. A. Gimbrone, Jr., Eds.: 83-118. Academic Press, Inc. New York.
109. ZWEIER, J. L., P. KUPPUSAMY & G. A. LUTTY. 1988. Measurement of endothelial cell free radical generation: Evidence for a central mechanism of free radical injury in post-ischemic tissue. Proc. Natl. Acad. Sci. USA 85: 4046-4050.